再次胸骨切开冠状动脉旁路移植术的容量-结局关系
基于胸外科医师学会成人心脏手术数据库2010至2019年数据,分析1,362,218例首次冠状动脉旁路移植术和93,985例再次胸骨切开冠状动脉旁路移植术患者。结果显示仅在术者层面,总心脏手术量越高,再次胸骨切开冠状动脉旁路移植术的死亡率和并发症率越低,医院层面调整后关联无统计学意义。
要点
- 术者层面手术量每增加100例,死亡调整比值比0.39(95%CI 0.24-0.61),并发症调整比值比0.37(95%CI 0.28-0.48)。
- 医院层面年手术量超过约200-300例、术者层面超过约100-150例后,死亡率和并发症率不再进一步改善。
- 再次胸骨切开冠状动脉旁路移植术的结局关键在于术者个人经验而非医院规模。
核心结论
- 仅在术者层面观察到总心脏手术量与再次胸骨切开冠状动脉旁路移植术结局呈负相关,提示术者个人经验而非医院规模是关键决定因素。
研究设计与样本
- 研究分析了胸外科医师学会成人心脏手术数据库中2010年至2019年报告的1,362,218例首次冠状动脉旁路移植术和93,985例再次胸骨切开冠状动脉旁路移植术患者。
- 主要结局为医院层面和术者层面计算的院内死亡率和死亡率与并发症率,按6个总心脏手术量类别进行比较。
- 采用多变量广义线性混合效应模型,以连续病例量为主要暴露变量,调整患者特征及术者和医院内变异。
主要发现
- 从最低到最高病例量类别,再次胸骨切开冠状动脉旁路移植术的未调整死亡率和死亡率与并发症率下降:医院层面死亡率3.9% ± 0.6%降至3.3% ± 0.1%,死亡率与并发症率18.5% ± 1.1%降至15.7% ± 0.4%,P < .001;术者层面死亡率4.1% ± 0.3%至4.1% ± 1.3%,死亡率与并发症率18.5% ± 0.6%降至14.5% ± 2.2%,P < .001。
- 观察结局与连续手术量的关系显示,超过最低年手术量(医院约200-300例;术者约100-150例)后,死亡率和死亡率与并发症率不再进一步改善。
- 使用个体水平数据并调整患者特征及术者和医院内聚类后,发现更高手术量与术者层面结局改善相关:死亡调整比值比0.39/100例手术(95%CI 0.24-0.61);死亡率与并发症率调整比值比0.37/100例手术(95%CI 0.28-0.48);两者P < .001。
- 医院层面调整后的容量-结局关联无统计学意义。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We assessed volume-outcome relationships of resternotomy coronary artery bypass grafting (CABG). METHODS: We studied 1,362,218 first-time CABG and 93,985 resternotomy CABG patients reported to The Society of Thoracic Surgeons Adult Cardiac Surgery Database between 2010 and 2019. Primary outcomes were in-hospital mortality and mortality and morbidity (M&M) rates calculated per hospital and per surgeon. Outcomes were compared across 6 total cardiac surgery volume categories. Multivariable generalized linear mixed-effects models were used considering continuous case volume as the main exposure, adjusting for patient characteristics and within-surgeon and hospital variation. RESULTS: We observed a decline in resternotomy CABG unadjusted mortality and M&M from the lowest to the highest case-volume categories (hospital-level mortality, 3.9% ± 0.6% to 3.3% ± 0.1%; M&M, 18.5% ± 1.1% to 15.7% ± 0.4%, P < .001; surgeon-level mortality, 4.1% ± 0.3% to 4.1% ± 1.3%; M&M, 18.5% ± 0.6% to 14.5% ± 2.2%, P < .001). Looking at outcomes vs continuous volume showed that beyond a minimum annual volume (hospital 200-300 cases; surgeon 100-150 cases, approximately), mortality and M&M rates did not further improve. Using individual-level data and adjusting for patient characteristics and clustering within surgeon and hospital, we found higher procedural volume was associated with improved surgeon-level outcomes (mortality adjusted odds ratio, 0.39/100 procedures; 95% CI, 0.24-0.61; M&M adjusted odds ratio, 0.37/100 procedures; 95% CI, 0.28-0.48; P < .001 for both). Hospital-level adjusted volume-outcomes associations were not statistically significant. CONCLUSIONS: We observed an inverse relationship between total cardiac case volume and resternotomy CABG outcomes at the surgeon level only, indicating that individual surgeon's experience, rather than institutional volume, is the key determinant.
引用
- Rappoport N, Shahian DM, Galai N, et al. Volume-Outcome Relationship of Resternotomy Coronary Artery Bypass Grafting. Ann Thorac Surg. 2022. PMID: 36328096. doi:10.1016/j.athoracsur.2022.09.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。